TG Therapeutics
TGTX
TGTX
355 hedge funds and large institutions have $3.65B invested in TG Therapeutics in 2025 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 142 increasing their positions, 105 reducing their positions, and 63 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
6% less capital invested
Capital invested by funds: $3.88B → $3.65B (-$232M)
25% less first-time investments, than exits
New positions opened: 47 | Existing positions closed: 63
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
355
Holding in Top 10
5
Calls
$106M
Puts
$77M
Top Buyers
| 1 | +$43.1M | |
| 2 | +$26.7M | |
| 3 | +$25.9M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$22.3M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$20.8M |
Top Sellers
| 1 | -$49.9M | |
| 2 | -$24.1M | |
| 3 | -$22.4M | |
| 4 |
Pictet Asset Management
Carouge,
Switzerland
|
-$18.2M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$17.6M |